Company Profile for GeneFluidics.

Business Editors

--(BUSINESS WIRE)

GeneFluidics is commercializing a novel technology platform that integrates bionanotechnology and microfluidics. The platform's components, which include a reader and disposable sensors and cartridges

List of rifle cartridges
List of handgun cartridges
Table of pistol and rifle cartridges
List of cartridges by caliber

, rapidly detect and quantify Quantify - A performance analysis tool from Pure Software. the presence of target genetic material, proteins, and small molecules in raw samples without the use of target amplification amplification /am·pli·fi·ca·tion/ (33000) (am?pli-fi-ka´shun) the process of making larger, such as the increase of an auditory stimulus, as a means of improving its perception. methods such as PCR PCR polymerase chain reaction.

PCR
abbr.
polymerase chain reaction

Polymerase chain reaction (PCR) . Based in high-throughput plastic injection molding injection molding
n.
A manufacturing process for forming objects, as of plastic or metal, by heating the molding material to a fluid state and injecting it into a mold. and other low-cost manufacturing methods, the GeneFluidics platform will dramatically reduce the cost of molecular analysis.


   Company:                GeneFluidics

   Headquarters Address:   2540 Corporate Place, Suite B101
                           Monterey Park, CA 91754

   Main Telephone:         323-269-0900

   Website:                http://www.genefluidics.com

   Type of Organization:   Private

   Industry:               Health: Biotechnology

   Key Executives:         CEO: Vincent Gau
                           Vice President: John Kibler

   Corporate Development
     Contact:              John Kibler
     Phone:                323-269-0900
     Email:                jkibler@genefluidics.com

COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.

Reader Opinion

Article Details
Printer friendly Cite/link Email Feedback
Publication:	Business Wire
Date:	Nov 7, 2003
Words:	125
Previous Article:	Company Profile for Motion Engineering, Inc.
Next Article:	Company Profile for Brave New Markets, Inc.

Related Articles
Fox & Fowle Architects.
Dr. Edward McCabe Joins GeneFluidics' Board of Advisors.
Restaurante Botin.
UCLA/VA Study Demonstrates the Rapid Diagnosis of Urinary Tract Infections with GeneFluidics' Novel Biosensor Technology.
The US, Japan and Germany Have Been Playing a Dominant Role in the Nanotechnology Market but Now New Markets Are Emerging in China and Taiwan.
Worldwide Markets for Nanobiotechnology in US$ Million with Annual Forecasts for Each Region 2000 Through 2010.